254 related articles for article (PubMed ID: 15454175)
21. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
[TBL] [Abstract][Full Text] [Related]
22. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
[TBL] [Abstract][Full Text] [Related]
23. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.
Cox ZL; Calcutt MW; Morrison TB; Akers WS; Davis MB; Lenihan DJ
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):433-8. PubMed ID: 23695773
[TBL] [Abstract][Full Text] [Related]
24. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
[TBL] [Abstract][Full Text] [Related]
25. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
26. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
[TBL] [Abstract][Full Text] [Related]
27. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
28. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
Rhee EK; Canter CE; Basile S; Webber SA; Naftel DC
J Heart Lung Transplant; 2007 May; 26(5):447-52. PubMed ID: 17449412
[TBL] [Abstract][Full Text] [Related]
29. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?
Haglund NA; Cox ZL; Lee JT; Song Y; Keebler ME; DiSalvo TG; Maltais S; Lenihan DJ; Wigger MA
J Card Fail; 2014 Sep; 20(9):630-7. PubMed ID: 24954426
[TBL] [Abstract][Full Text] [Related]
30. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
Collins JA; Skidmore MA; Melvin DB; Engel PJ
J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
[TBL] [Abstract][Full Text] [Related]
31. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
32. [The effects of intravenous milrinone for the patient undergoing CABG].
Yasuda F; Shimono T; Cruz BP; Komada T; Tokui T; Onoda K; Tanaka K; Shimpo H; Yada I; Okuda M; Utsunomiya H; Maruyama K
Kyobu Geka; 2000 Feb; 53(2):117-21. PubMed ID: 10667021
[TBL] [Abstract][Full Text] [Related]
33. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
34. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
Curley M; Liebers J; Maynard R
J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
[TBL] [Abstract][Full Text] [Related]
35. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
36. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
37. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
[TBL] [Abstract][Full Text] [Related]
38. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
39. Correlation between plasma milrinone concentration and renal function in patients with cardiac disease.
Hasei M; Uchiyama A; Nishimura M; Mashimo T; Fujino Y
Acta Anaesthesiol Scand; 2008 Aug; 52(7):991-6. PubMed ID: 18477069
[TBL] [Abstract][Full Text] [Related]
40. Hospital readmission in patients with implantable cardioverter-defibrillators.
Kaźmierczak J; Zielonka J; Rzeuski R; Peregud-Pogorzelska M; Goracy J; Biernawska J; Sulikowski T; Kornacewicz-Jach Z
Kardiol Pol; 2006 Jul; 64(7):684-91; discussion 692-3. PubMed ID: 16886125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
